Investigational Drug Service, Emory University Clinic — Atlanta, Georgia

Investigational Drug Service, Emory University Clinic is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Drug Service, Emory University Clinic has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Ovarian Cancer, Acute Lymphoblastic Leukemia.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Service, Emory University Clinic?

Investigational Drug Service, Emory University Clinic has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Service, Emory University Clinic conducted?

Investigational Drug Service, Emory University Clinic has 4 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia, Ovarian Cancer, Acute Lymphoblastic Leukemia.

Is Investigational Drug Service, Emory University Clinic accredited by Crixeo Health?

Investigational Drug Service, Emory University Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Service, Emory University Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.